drugset / Trial / NCT07220551
A Phase 1 Relative Bioavailability Study of UCB0022 Tablets in Healthy Participants
RandomizedCrossoverOpen-labelBasic science
Summary
The purpose of this study is to estimate the relative bioavailability of UCB0022 Formulation 2 (Test) versus Formulation 1 (Reference) in healthy participants following single oral administration.
Timeline
- Start
- 2025-10-23
- Primary completion
- 2025-12-16
- Completion
- 2025-12-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | glovadalen | Small molecule | — | Oral |
Indications
No indication recorded.